Skip to main content
. 2022 Oct;11(10):1639–1646. doi: 10.21037/gs-22-459

Figure 2.

Figure 2

Diagnostic value of the SII for predicting neoadjuvant chemotherapy inefficacy in patients with stage III ovarian cancer. SII, systemic immune-inflammation index.